Fellows are encouraged to be involved in clinical or laboratory research during the 24 month Fellowship. Each fellow must present a research project at least once during their fellowship at the department's annual Research Conference.
The Vitreoretinal Service is actively involved in clinical and laboratory investigations. The Fellows have access to the Experimental Surgery Unit as well as all laboratories within the Department if arrangements are made with the appropriate supervisors of those laboratories. An EyeSi vitrectomy simulator is also available to fellows at the Veterans Affairs Hospital.
The Retina Service is a regular site for major nationwide collaborative studies including:
- Gene therapy for Leber Congenital Amaurosis Trial (phase II/III)
- Gene therapy for AMD (phase I)
- Visual cycle modulator for dry AMD
- Comparisons of Age-Related Macular Degeneration Treatments Trial (CATT)
- VIEW1 (VEGF-trap)
- The Collaborative Ocular Melanoma Study (COMS)
- Choroidal Neovascularization Prevention Trial (CNVPT)
- Submacular Surgery Trials (SST)
- Anecortave Acetate Study
- Complications of Age-Related Macular Degeneration Prevention Trial (CAPT)
- Protein Kinase C Inhibitor Study of Diabetic Retinopathy.
- The Vitreoretinal Service has functioned as both an investigative center and as the national Photography Reading Center for the Collaborative Ocular Melanoma Study (COMS).
Research studies in large and small animals utilizing novel therapies such as stem cells, gene therapy, and optogenetics are also being conducted through Dr. Elliott Sohn, Steve Russell, and Ed Stone in conjunction with the Institute for Vision Research